Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 September 2025 | Story Onthatile Tikoe | Photo Supplied
Dr Phindile Shangase
Dr Phindile Shangase, Senior Lecturer in the UFS Faculty of Health Sciences, was honoured with a Carnegie Fellowship for her impactful global public health collaboration.

The University of the Free State (UFS) is proud to announce that Dr Phindile Shangase, Senior Lecturer in the Faculty of Health Sciences and academic leader, has been selected for the highly competitive Carnegie African Diaspora Fellowship Programme (CADFP).

The CADFP links African-born academics based in the United States and Canada with universities across Africa to strengthen teaching, research, and mentorship. As part of her fellowship, Dr Shangase will host Dr Mufaro Kanyangarara, Assistant Professor at the University of South Carolina.

Reflecting on the award, Dr Shangase said, “When I received the news that I had been selected as part of the CADFP, I felt deeply honoured and humbled. The recognition affirmed not only my academic journey and professional contributions, but also the value of creating meaningful global collaborations.”

 

Collaborative project for public health impact

Dr Shangase’s project will focus on collaborative curriculum development, designed to enhance education, research, and mentorship through diaspora partnerships. The initiative aims to strengthen research skills among postgraduate students, with a particular focus on addressing the quadruple burden of disease faced by low- and middle-income countries (LMICs).

“This project will empower students to contribute to global health knowledge through impactful research and publications. It also aligns with the UFS’ strategic vision, Vision 130, which emphasises global collaboration in teaching and research,” she explained.

Dr Kanyangarara brings expertise in global health, epidemiology, and biostatistics, while Dr Shangase contributes extensive knowledge of public health teaching and the social determinants of health. Their complementary strengths will help shape the next generation of public health professionals.

 

Building capacity and global partnerships

The fellowship is expected to prepare students for leadership roles in public health, both locally and internationally. Opportunities for exchange and exposure to global collaborations will broaden their academic and professional horizons.

Looking beyond the fellowship, Dr Shangase noted that sustainability will be achieved through continued collaboration. “Dr Kanyangarara will remain involved as a collaborator in curriculum development and as a hybrid guest lecturer and research fellow. Sustainability will also be fostered through joint research initiatives, co-authored publications, and grant proposals.”

 

Advice for emerging scholars

Encouraging young academics, Dr Shangase said, “Remain steadfast in pursuing excellence while staying grounded in the unique contexts and needs of our continent. International fellowships such as the CADFP are not only about personal achievement, but also about creating meaningful impact through collaboration, mentorship, and knowledge exchange.”

Her selection reflects the UFS’ growing role as a hub for global health scholarship and its commitment to addressing pressing public health challenges through international collaboration.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept